Skip to main content
Premium Trial:

Request an Annual Quote

Jubilant Biosys licenses its Kinase ChemBioBase to Astex Technology

NEW YORK, July 8 - Jubilant Biosys of Bangalore, India said today that it has licensed its kinase target database to Astex Technology, of Cambridge, UK.


Under the license, Astex will be able to use the database, called the Kinase ChemBioBase, in its structure-based research on lead compounds for drug discovery.


The content in this database is what gives Jubilant a competitive edge, according to Sreeni Devidas, vice president of business development and strategy at Jubilant. The database "has all the relevant information that has never been worked on in kinases," he said, including "over 170,000 compounds and 200,000 structure-activity relationships."


Jubilant provides bioinformatics and chemoinformatics services.


The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.